{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:44:45Z","timestamp":1791139485259,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":4352,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1111\/j.1087-0024.2004.00825.x","type":"journal-article","created":{"date-parts":[[2004,1,7]],"date-time":"2004-01-07T13:54:30Z","timestamp":1073483670000},"page":"68-72","source":"Crossref","is-referenced-by-count":96,"title":["Autoimmune Aspects of Depigmentation in Vitiligo"],"prefix":"10.1016","volume":"9","author":[{"given":"I. Caroline","family":"Le poole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wa\u00f1kowicz-kali\u00f1ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 MJGJ","family":"van den Wijngaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Nickoloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranab K.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0010","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/hmg\/11.6.661","article-title":"Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-P32.2","volume":"11","author":"Alkhateeb","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0015","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/intimm\/12.11.1539","article-title":"Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a maturation signal to dendritic cells and activate the NF-kappa B pathway","volume":"12","author":"Basu","year":"2002","journal-title":"Int Immunol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0020","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1523-1747.1999.00805.x","article-title":"Accumulation of identical T cells in melanoma and vitiligo-like leukoderma","volume":"113","author":"Becker","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/1523-1747.ep12480976","article-title":"Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients","volume":"97","author":"Boissy","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0030","first-page":"23","article-title":"Vitiligo is associated with HLA-A2 and HLA-Dw7 in the Slovak populations","volume":"42","author":"Buc","year":"1996","journal-title":"Folia Biol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0035","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1006\/bbrc.1997.7849","article-title":"Melanin-concentrating hormone binding sites in human SVK14 keratinocytes","volume":"29","author":"Burgaud","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1034\/j.1600-0749.2002.00057.x","article-title":"Genetic association of the catalase gene (CAT) with vitiligo susceptibility","volume":"15","author":"Casp","year":"2002","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1471-4906(00)01844-5","article-title":"A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo","volume":"22","author":"Das","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1034\/j.1600-065X.2002.18812.x","article-title":"Antigens derived from melanocyte differentiation proteins, self-tolerance, autoimmunity, and use for cancer immunotherapy","volume":"188","author":"Engelhard","year":"2002","journal-title":"Immunol Rev"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0055","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12324456","article-title":"In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo","volume":"105","author":"Gilhar","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0060","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","article-title":"Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo","volume":"97","author":"Harning","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2340\/0001555574124128","article-title":"High-frequency of thyroid dysfunction in patients with vitiligo","volume":"74","author":"Hegedus","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0070","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/1523-1747.ep12476645","article-title":"Presence or absence of melanocytes in vitiligo lesions: an immunhistochemical investigation","volume":"100","author":"Le Poole","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0075","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.4049\/jimmunol.168.4.1823","article-title":"Innate direct anticancer effector function of human immature dendritic cells. I. Involvement of an apoptosis-inducing pathway","volume":"168","author":"Janjic","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00002371-199807000-00001","article-title":"The use of melanosomal proteins in the immunotherapy of melanoma","volume":"21","author":"Kawakami","year":"1998","journal-title":"J Immunother"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0085","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0214643","article-title":"The melanocortin receptor 1, a novel target of autoantibody responses in vitiligo 2002","volume":"109","author":"Kemp","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0090","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.4049\/jimmunol.151.12.7284","article-title":"A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders","volume":"151","author":"Le Poole","year":"1993","journal-title":"J Immunol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0095","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9440(10)64871-7","article-title":"Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells","volume":"160","author":"Le Poole","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1034\/j.1600-0749.2001.140608.x","article-title":"\u2018VIT1\u2019, a novel gene associated with vitiligo","volume":"14","author":"Le Poole","year":"2001","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0105","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0110","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.4049\/jimmunol.168.4.1831","article-title":"Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha (1) beta (2), Fas ligand, and TNF-related apoptosis-inducing ligand","volume":"168","author":"Lu","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s102270000030","article-title":"Ultraviolet (UV) regulation of the TNF family decoy receptors DcR2 and DcR3 in human keratinocytes","volume":"5","author":"Maeda","year":"2001","journal-title":"Cutan Med Surg"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0065-2776(08)60911-6","article-title":"Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance","volume":"74","author":"Marincola","year":"2000","journal-title":"Adv Immunol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0125","first-page":"441","article-title":"Succussful culture of adult human melanocytes obtaines from normal and vitiligo donors","volume":"95","author":"Medrano","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.158.1.246","article-title":"Antibodies to normal melanocytes in vitiligo","volume":"158","author":"Naughton","year":"1983","journal-title":"J Exp Med"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0135","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: A good prognostic sign","volume":"9","author":"Nordlund","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0733-8635(05)70416-2","article-title":"Recent investigations on vitiligo vulgaris","volume":"15","author":"Nordlund","year":"1997","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0749.1994.tb00049.x","article-title":"Melanocyte destruction and repopulation in vitiligo","volume":"7","author":"Norris","year":"1994","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0150","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo. Patients' sera induce damage and antibody-dependent cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0155","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00043764-198806000-00014","article-title":"Occupational vitiligo due to unsuspected presence of phenolic antioxidant byproducts in commercial bulk rubber","volume":"30","author":"O'Malley","year":"1988","journal-title":"J Occup Med"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0160","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocytes cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0165","series-title":"Vitiligo and Other Hypomelanoses of Hair and Skin","first-page":"1","author":"Ortonne","year":"1983"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0170","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1073\/pnas.96.6.2982","article-title":"Vaccination with a recombinant vaccinia virus encoding a \u2018self\u2019 antigen induces autoimmune vitiligo and tumor cell destruction in mice. Requirement for Cd4+ T Lymphocytes","volume":"96","author":"Overwijk","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0175","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1615\/CritRevImmunol.v20.i6.10","article-title":"Autoimmunity and the immunotherapy of cancer: Targeting the \u2018self\u2019 to destroy the \u2018other\u2019","volume":"20","author":"Overwijk","year":"2000","journal-title":"Crit Rev Immunol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0180","first-page":"251","article-title":"Vitiligo in the SSK community of Bangalore","volume":"54","author":"Ramaiah","year":"1988","journal-title":"Indian J Dermatol Lepr"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00008390-199704000-00001","article-title":"Melanosomal proteins as melanoma-specific immune targets","volume":"7","author":"Sakai","year":"1997","journal-title":"Melanoma Res"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0190","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000057881","article-title":"Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed Caucasian patients with vitiligo","volume":"204","author":"Schallreuter","year":"2002","journal-title":"Dermatology"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0195","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/S0264-410X(00)00492-8","article-title":"Heat shock proteins. The \u2018Swiss Army Knife\u2019 vaccines against cancers and infectious agents","volume":"19","author":"Srivastava","year":"2001","journal-title":"Vaccine"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0200","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1074-7613(02)00327-8","article-title":"Redundant and alternative roles for activating the receptors and complement in an antibody-dependent model of autoimmune vitiligo","volume":"16","author":"Trcka","year":"2002","journal-title":"Immunity"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0205","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1084\/jem.194.4.481","article-title":"Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy","volume":"194","author":"Van Elzas","year":"2001","journal-title":"J Exp Med"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0210","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/1993\/356874","article-title":"HLA associations in vitiligo patients in the Dutch population","volume":"11","author":"Venneker","year":"1993","journal-title":"Dis Markers"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0215","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0171-2985(98)80054-5","article-title":"Relative contributions of decay acceleration factor (DAF), membrane cofactor protein (MCP) and CD59 in the protection of melanocytes from homologous complement","volume":"198","author":"Venneker","year":"1998","journal-title":"Immunobiology"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0220","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.4049\/jimmunol.163.11.5820","article-title":"A role for a melansome transport signal in accessing the MHC class II presentation pathway and eliciting CD4+ T cell responses","volume":"163","author":"Wang","year":"1999","journal-title":"J Immunol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1365-2133.2002.04604.x","article-title":"Aberrant expression of complement regulatory proteins, membrane cofactor protein (MCP) and decay accelerating factor (DAF) in the involved epidermis of patients with vitiligo","volume":"146","author":"van den Wijngaard","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0230","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2133.2000.03712.x","article-title":"Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo","volume":"143","author":"van den Wijngaard","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0235","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780138","article-title":"Local immune response in skin of generalized vitiligo patients: Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site","volume":"80","author":"van den Wijngaard","year":"2000","journal-title":"Lab Invest"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0240","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/labinvest.3780318","article-title":"Autoimmune melanocyte destruction in vitiligo","volume":"81","author":"van den Wijngaard","year":"2001","journal-title":"Lab Invest"},{"key":"10.1111\/j.1087-0024.2004.00825.x_bb0245","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","article-title":"Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo","volume":"192","author":"Yee","year":"2000","journal-title":"J Exp Med"}],"container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15529850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15529850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T21:44:21Z","timestamp":1734212661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15529850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0022202X15529850"],"URL":"https:\/\/doi.org\/10.1111\/j.1087-0024.2004.00825.x","relation":{},"ISSN":["1087-0024"],"issn-type":[{"value":"1087-0024","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}